Latest PRTG reports update at 2022-08-01: 2022 ∙ 2021 ∙ 2020

Portage Biotech PRTG

$ 0.26 -10.17%

Portage Biotech Balance Sheet 2011-2024 | PRTG

Annual Balance Sheet Portage Biotech

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	28.4 M	24 M	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	29.2 M	27.3 M	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-55 M	-38.1 M	-	-	-	-	-	-	-	-	-	-
Total Assets	195 M	175 M	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	23.4 M	2.77 M	3.15 M	6.17 M	7.52 M	159 K	-	-	-	-	-	-
Book Value	165 M	148 M	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	165 M	148 M	146 M	149 M	9.62 M	59.6 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Portage Biotech

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	23.6 M	23.5 M	24.2 M	24 M	-	-	-	25 M	-	-	-	23.4 M	-	-	-	233 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	24.2 M	24.9 M	26.7 M	27.3 M	-	-	-	27.5 M	-	-	-	25.2 M	-	-	-	384 K	-	-	-	310 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-47.7 M	-44.2 M	-41.2 M	-38.1 M	-	-	-	-22.3 M	-	-	-	-17 M	-	-	-	-14.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	196 M	198 M	200 M	175 M	-	-	-	173 M	-	-	-	174 M	-	-	-	10 M	-	-	-	59.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	25.6 M	27.3 M	28.6 M	2.77 M	3.64 M	4.43 M	8.2 M	3.15 M	-	-	-	6.17 M	-	-	-	7.52 M	-	-	-	159 K	-	-	-	4.69 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	172 M	174 M	174 M	148 M	-	-	-	146 M	-	-	-	149 M	-	-	-	9.62 M	-	-	-	59.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	172 M	174 M	174 M	148 M	152 M	149 M	152 M	146 M	-	-	-	149 M	-	-	-	9.62 M	-	-	-	59.6 M	-	-	-	12.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency